Eric Bironneau brings over two decades of commercial leadership experience to the company, including serving as Vice President, Global Sales & Business Development at Axplora and Novasep.

As Chief Business Officer, Eric has responsibility for Quotient Sciences’ commercial organization including drug product, clinical, Translational Pharmaceutics® and commercial lines, as well as for Quotient Sciences’ strategic partnerships.